# Effect and Safety of Local Injection of Botulinum Toxin Type B Against Digital Ulcer in Systemic Sclerosis

> **NCT03007004** · PHASE2 · COMPLETED · sponsor: **Gunma University** · enrollment: 10 (actual)

## Conditions studied

- Systemic Sclerosis Patients With Digital Ulcers

## Interventions

- **DRUG:** Botulinum toxin type B (2500 units / vial)
- **DRUG:** Physiological saline

## Key facts

- **NCT ID:** NCT03007004
- **Lead sponsor:** Gunma University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12-12
- **Primary completion:** 2019-05-14
- **Final completion:** 2019-05-14
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2020-05-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03007004

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03007004, "Effect and Safety of Local Injection of Botulinum Toxin Type B Against Digital Ulcer in Systemic Sclerosis". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03007004. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*